Use of sphingolipid analogs: benefits and risks |
| |
| Authors: | Riccardo Ghidoni Giusy Sala Attilia Giuliani |
| |
| Affiliation: | 1. INSERM U410, Neuroendocrinologie et Biologie Cellulaire Digestives, Faculté de Médecine Xavier Bichat, Paris, France;2. Department of Medical Chemistry and Biochemistry, University of Milan, Milan, Italy |
| |
| Abstract: | |
| |
| Keywords: | Ceramide Sphingosine Glycosphingolipid Sphingomyelin Short-chain NBD Apoptosis ACAT, acylCoa:cholesterol:acyltransferase ACh, acetylcholine Bimane, bimanoylthyo BFA, brefeldin A Cer, ceramide (only in complex terms) CHO, Chinese hamster ovary DECA, diethylaminocoumarin DH, dihydro DHC, dihexosylceramide DMS, dimethylsphingosine DMSO, dimethylsulfoxide EGF, epidermal growth factor ESR, electron spin resonance exog, exogenous GalCer, galactosylceramide GlcCer, glucosylceramide GSL, glycosphingolipid IL, interleukin LacCer, lactosylceramide MDCK, Madin-Darby canine kidney MDR, multidrug resistance nat, natural NGF, nerve growth factor PA, phosphatidic acid PAF, platelet activating factor PC, phosphatidylcholine PL, phospholipid PKC, protein kinase C PP2A, protein phosphatase 2A, PSA, pyrene-sulfonylamide SL, sphingolipid SM, sphingomyelin SMase, sphingomyelinase Sph, sphingosine (only in complex terms) SPP, sphingosine-1-phosphate THC, trihexosylceramide TMS, trimethylsphingosine TNF, tumor necrosis factor Vit, vitamine |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
